BioCorRx Strengthens Intellectual Property Portfolio with Acquisition of Several Patent/Patent Pending Families
October 19, 2018 07:30 ET
|
BioCorRx Inc
Issued patents, in addition to other intellectual property (IP) rights, cover hydrophobic drug-delivery material for BICX101 Divisional patent applications filed to strengthen BioCorRx’s ...
BioCorRx CEO Brady Granier Discusses BioCorRx Recovery Program on This Life #YouLive Podcast Hosted by Dr. Drew
September 25, 2018 11:11 ET
|
BioCorRx Inc
ANAHEIM, CA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE-- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid...
Actor Jeremy Miller Appears on Local ABC News Supporting BioCorRx Recovery Program
September 12, 2018 07:43 ET
|
BioCorRx Inc
ANAHEIM, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid...
BioCorRx Provides Business Update for the Second Quarter of 2018
August 15, 2018 08:00 ET
|
BioCorRx Inc
ANAHEIM, CA, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided...
BioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone Implant
April 30, 2018 07:00 ET
|
BioCorRx Inc
ANAHEIM, CA, April 30, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx to Participate in the First Annual Orange County Recovery Collaborative Resource Fair
April 13, 2018 07:19 ET
|
BioCorRx Inc
ANAHEIM, CA, April 13, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company), a developer and provider of advanced solutions in the treatment of alcohol and opioid addition, today...
BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction
April 09, 2018 12:25 ET
|
BioCorRx Inc
ANAHEIM, CA, April 09, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx Provides Business Update for the Full Year Ended 2017
April 06, 2018 07:30 ET
|
BioCorRx Inc
ANAHEIM, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
BioCorRx Comments on President Donald J. Trump’s Initiative to Stop Opioid Abuse
March 20, 2018 10:40 ET
|
BioCorRx Inc
ANAHEIM, CA, March 20, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102
February 12, 2018 09:23 ET
|
BioCorRx Inc
505(b)(2) application plan acceptable per FDA Application will seek dual indications for opioid and alcohol use disorders ANAHEIM, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioCorRx...